BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001. [PMID: 1886637 DOI: 10.1056/NEJM199110033251404] [Cited by in Crossref: 705] [Cited by in F6Publishing: 725] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Chung EYM, Badve SV, Heerspink HJL, Wong MG. Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond? Nephrology (Carlton) 2023;28:97-108. [PMID: 36350038 DOI: 10.1111/nep.14130] [Reference Citation Analysis]
2 Tryfonos A, Mills J, Green DJ, Wagenmakers AJM, Dawson EA, Cocks M. Association between atherogenic risk-modulating proteins and endothelium-dependent flow-mediated dilation in coronary artery disease patients. Eur J Appl Physiol 2023;123:367-80. [PMID: 36305972 DOI: 10.1007/s00421-022-05040-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Inggriani MP, Musthafa A, Puspitawati I, Fachiroh J, Dewi FST, Hartopo AB. Increased endothelin-1 levels in coronary artery disease with diabetes mellitus in an Indonesian population. Can J Physiol Pharmacol 2022. [DOI: 10.1139/cjpp-2022-0011] [Reference Citation Analysis]
4 Kuczmarski AV, Welti LM, Moreau KL, Wenner MM. ET-1 as a Sex-Specific Mechanism Impacting Age-Related Changes in Vascular Function. Front Aging 2021;2:727416. [PMID: 35822003 DOI: 10.3389/fragi.2021.727416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shishikura D, Octavia Y, Hayat U, Thondapu V, Barlis P. Atherogenesis and Inflammation. In: Dangas GD, Di Mario C, Thiele H, Barlis P, Addo T, Claessen B, Hengstenberg C, Kipshidze N, editors. Interventional Cardiology. Wiley; 2022. pp. 1-20. [DOI: 10.1002/9781119697367.ch1] [Reference Citation Analysis]
6 Jukema RA, de Winter RW, van Diemen PA, Driessen RS, Danser AJ, Garrelds IM, Raijmakers PG, van de Ven PM, Knaapen P, Danad I, de Waard GA. The relation of RAAS activity and endothelin-1 levels to coronary atherosclerotic burden and microvascular dysfunction in chest pain patients. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Quyyumi AA, Almuwaqqat Z, Islam SJ. Clinical investigations of vascular function. The Vasculome 2022. [DOI: 10.1016/b978-0-12-822546-2.00019-8] [Reference Citation Analysis]
8 Willems LH, Nagy M, Ten Cate H, Spronk HMH, Groh LA, Leentjens J, Janssen NAF, Netea MG, Thijssen DHJ, Hannink G, van Petersen AS, Warlé MC. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res 2022;209:106-14. [PMID: 34922160 DOI: 10.1016/j.thromres.2021.11.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Willems L, Thijssen D, Donders A, van der Vijver-coppen R, Groh L, Reijnen M, Warlé M. A protocol for DUAL pathway inhibition (low-dose rivaroxaban and aspirin) as compared to aspirin only to improve endothelial function in peripheral artery disease. Medicine: Case Reports and Study Protocols 2021;2:e0163. [DOI: 10.1097/md9.0000000000000163] [Reference Citation Analysis]
10 Kostov K. The Causal Relationship between Endothelin-1 and Hypertension: Focusing on Endothelial Dysfunction, Arterial Stiffness, Vascular Remodeling, and Blood Pressure Regulation. Life (Basel) 2021;11:986. [PMID: 34575135 DOI: 10.3390/life11090986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
11 Torres Crigna A, Link B, Samec M, Giordano FA, Kubatka P, Golubnitschaja O. Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine. EPMA J 2021;:1-41. [PMID: 34367381 DOI: 10.1007/s13167-021-00248-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
12 MacLeod C, Hadoke PWF, Nixon M. Glucocorticoids: Fuelling the Fire of Atherosclerosis or Therapeutic Extinguishers? Int J Mol Sci 2021;22:7622. [PMID: 34299240 DOI: 10.3390/ijms22147622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Günay Ş, Sarandöl E, Aydinlar A. Subklinik aterosklerozun Serum Endotelin-1 Düzeyi ile Değerlendirilmesi. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2021. [DOI: 10.32708/uutfd.857404] [Reference Citation Analysis]
14 Oh S, Son M, Park CH, Jang JT, Son KH, Byun K. The Reducing Effects of Pyrogallol-Phloroglucinol-6,6-Bieckol on High-Fat Diet-Induced Pyroptosis in Endothelial and Vascular Smooth Muscle Cells of Mice Aortas. Mar Drugs 2020;18:E648. [PMID: 33339328 DOI: 10.3390/md18120648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Ouerd S, Idris-Khodja N, Trindade M, Ferreira NS, Berillo O, Coelho SC, Neves MF, Jandeleit-Dahm KA, Paradis P, Schiffrin EL. Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1. Cardiovasc Res 2021;117:1144-53. [PMID: 32533834 DOI: 10.1093/cvr/cvaa168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Li P, Schmidt IM, Sabbisetti V, Tio MC, Opotowsky AR, Waikar SS. Plasma Endothelin-1 and Risk of Death and Hospitalization in Patients Undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol 2020;15:784-93. [PMID: 32381583 DOI: 10.2215/CJN.11130919] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Brewster LM, Garcia VP, Levy MV, Stockelman KA, Goulding A, DeSouza NM, Greiner JJ, Hijmans JG, DeSouza CA. Endothelin-1-induced endothelial microvesicles impair endothelial cell function. J Appl Physiol (1985) 2020;128:1497-505. [PMID: 32324474 DOI: 10.1152/japplphysiol.00816.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
18 Magnúsdóttir EI, Grujic M, Bergman J, Pejler G, Lagerström MC. Mouse connective tissue mast cell proteases tryptase and carboxypeptidase A3 play protective roles in itch induced by endothelin-1. J Neuroinflammation 2020;17:123. [PMID: 32321525 DOI: 10.1186/s12974-020-01795-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
19 Jones NK, Stewart K, Czopek A, Menzies RI, Thomson A, Moran CM, Cairns C, Conway BR, Denby L, Livingstone DEW, Wiseman J, Hadoke PW, Webb DJ, Dhaun N, Dear JW, Mullins JJ, Bailey MA. Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation. Hypertension 2020;75:1213-22. [PMID: 32200679 DOI: 10.1161/HYPERTENSIONAHA.119.14308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Xu J, Sun Y, Lu J. Knockdown of Long Noncoding RNA (lncRNA) AK094457 Relieved Angiotensin II Induced Vascular Endothelial Cell Injury. Med Sci Monit 2020;26:e919854. [PMID: 32027625 DOI: 10.12659/MSM.919854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
21 Liu S, Zhang L, Yan H, Zhang X, Wang L. Nesiritide protects endothelial function after balloon-induced trauma in the iliac artery in rabbits. Braz J Pharm Sci 2020;56:e18430. [DOI: 10.1590/s2175-97902019000418430] [Reference Citation Analysis]
22 Sutton G, Pugh D, Dhaun N. Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target? Am J Hypertens 2019;32:813-5. [PMID: 31145445 DOI: 10.1093/ajh/hpz091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
23 Miteva KT, Pedicini L, Wilson LA, Jayasinghe I, Slip RG, Marszalek K, Gaunt HJ, Bartoli F, Deivasigamani S, Sobradillo D, Beech DJ, McKeown L. Rab46 integrates Ca2+ and histamine signaling to regulate selective cargo release from Weibel-Palade bodies. J Cell Biol 2019;218:2232-46. [PMID: 31092558 DOI: 10.1083/jcb.201810118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
24 Wang F, Li T, Cong X, Hou Z, Lu B, Zhou Z, Chen X. Association between circulating big endothelin-1 and noncalcified or mixed coronary atherosclerotic plaques. Coron Artery Dis 2019;30:461-6. [PMID: 30994493 DOI: 10.1097/MCA.0000000000000752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 De Haro J, Bleda S, Gonzalez-Hidalgo C, Michel I, Acin F. Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term Outcome. Am J Cardiovasc Drugs 2019;19:203-9. [PMID: 30417231 DOI: 10.1007/s40256-018-0307-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wang F, Li T, Cong X, Hou Z, Lu B, Zhou Z, Chen X. The Value of Big Endothelin-1 in the Assessment of the Severity of Coronary Artery Calcification. Clin Appl Thromb Hemost 2018;24:1042-9. [PMID: 29562761 DOI: 10.1177/1076029618764846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Angeli F, Reboldi G, Trapasso M, Aita A, Turturiello D, Verdecchia P. Hypertensive Heart Disease. Updates in Hypertension and Cardiovascular Protection 2018. [DOI: 10.1007/978-3-319-59918-2_13] [Reference Citation Analysis]
28 Haas EA, Nishiyama M, da Luz PL. Clinical Endothelial Dysfunction: Prognosis and Therapeutic Target. Endothelium and Cardiovascular Diseases 2018. [DOI: 10.1016/b978-0-12-812348-5.00048-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Lund A. Oxidants and Endothelial Dysfunction. Comprehensive Toxicology 2018. [DOI: 10.1016/b978-0-12-801238-3.65250-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Renshall L, Arnold N, West L, Braithwaite A, Pickworth J, Walker R, Alfaidi M, Chamberlain J, Casbolt H, Thompson AAR, Holt C, Iglarz M, Francis S, Lawrie A. Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosis. Pulm Circ 2018;8:2045893217752328. [PMID: 29261014 DOI: 10.1177/2045893217752328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
31 Khalid W, Varghese SS, Sankari M, Jayakumar ND. Comparison of Serum Levels of Endothelin-1 in Chronic Periodontitis Patients Before and After Treatment. J Clin Diagn Res 2017;11:ZC78-81. [PMID: 28571268 DOI: 10.7860/JCDR/2017/24518.9698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
32 Skovsted GF, Kruse LS, Berchtold LA, Grell AS, Warfvinge K, Edvinsson L. Myocardial ischemia-reperfusion enhances transcriptional expression of endothelin-1 and vasoconstrictor ETB receptors via the protein kinase MEK-ERK1/2 signaling pathway in rat. PLoS One 2017;12:e0174119. [PMID: 28323857 DOI: 10.1371/journal.pone.0174119] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
33 Patel H, Alkhawam H, Madanieh R, Shah N, Kosmas CE, Vittorio TJ. Aerobic vs anaerobic exercise training effects on the cardiovascular system. World J Cardiol 2017; 9(2): 134-138 [PMID: 28289526 DOI: 10.4330/wjc.v9.i2.134] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 14.7] [Reference Citation Analysis]
34 Wang WJ, Zhou JH, He GL, Wu QL, Gao W, Sun JH, Zhang PB. Correlation Between Flow-Mediated Dilatation of the Brachial Artery and Serum Endothelial Biomarkers in the Evaluation of Acute Endothelial Injury After Cardiopulmonary Bypass. J Ultrasound Med 2017;36:631-8. [PMID: 28164350 DOI: 10.7863/ultra.16.02071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Nishiyama SK, Zhao J, Wray DW, Richardson RS. Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction. J Appl Physiol (1985) 2017;122:354-60. [PMID: 27909229 DOI: 10.1152/japplphysiol.00772.2016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
36 Hayat U, Thondapu V, Tsay T, Barlis P. Atherogenesis and Inflammation. Interventional Cardiology 2016. [DOI: 10.1002/9781118983652.ch1] [Reference Citation Analysis]
37 Guddeti RR, Prasad A, Matsuzawa Y, Aoki T, Rihal C, Holmes D, Best P, Lennon RJ, Lerman LO, Lerman A. Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for non-ST elevation acute coronary syndromes: a single-centre randomised controlled trial. Open Heart 2016;3:e000428. [PMID: 27547429 DOI: 10.1136/openhrt-2016-000428] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
38 Neff D, Kuhlenhoelter AM, Lin C, Wong BJ, Motaganahalli RL, Roseguini BT. Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease. Am J Physiol Regul Integr Comp Physiol 2016;311:R392-400. [PMID: 27335279 DOI: 10.1152/ajpregu.00147.2016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
39 Erqou S, Kip KE, Mulukutla SR, Aiyer AN, Reis SE. Endothelial Dysfunction and Racial Disparities in Mortality and Adverse Cardiovascular Disease Outcomes. Clin Cardiol 2016;39:338-44. [PMID: 27028406 DOI: 10.1002/clc.22534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
40 Horinouchi T, Hoshi A, Harada T, Higa T, Karki S, Terada K, Higashi T, Mai Y, Nepal P, Mazaki Y, Miwa S. Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells. Br J Pharmacol 2016;173:1018-32. [PMID: 26660861 DOI: 10.1111/bph.13406] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
41 De Haro J, Bleda S, Varela C, Esparza L, Acin F; Bosentan Population-Based Randomized Trial for Clinical and Endothelial Function Assessment on Endothelin Antagonist Therapy in Patients With Intermittent Claudication CLAU Investigators. Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial Disease. Am J Cardiol 2016;117:295-301. [PMID: 26651453 DOI: 10.1016/j.amjcard.2015.10.032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
42 Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol 2015; 7(11): 719-741 [PMID: 26635921 DOI: 10.4330/wjc.v7.i11.719] [Cited by in Crossref: 126] [Cited by in F6Publishing: 130] [Article Influence: 15.8] [Reference Citation Analysis]
43 Sorrentino FS, Bonifazzi C, Perri P. The Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis Pigmentosa. J Ophthalmol 2015;2015:405234. [PMID: 26613048 DOI: 10.1155/2015/405234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
44 Wang XX, Yang JX, Pan YY, Zhang YF. Protective effects of tanshinone ⅡA on endothelial progenitor cells injured by tumor necrosis factor-α. Mol Med Rep 2015;12:4055-62. [PMID: 26095681 DOI: 10.3892/mmr.2015.3969] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
45 Martin-conejero A, Modrego Martín J, Hernández Mateo M, Rodríguez Sierra P, Serrano Hernando F, López Farré A. Efectos del bosentán sobre la función vascular e inflamación de pacientes diabéticos con enfermedad vascular periférica. Angiología 2015;67:83-88. [DOI: 10.1016/j.angio.2014.09.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Martínez-salamanca JI, González J, Ramírez P, Angulo J. Vascular Erectile Dysfunction. PanVascular Medicine 2015. [DOI: 10.1007/978-3-642-37078-6_154] [Reference Citation Analysis]
47 Skovsted GF, Kruse LS, Larsen R, Pedersen AF, Trautner S, Sheykhzade M, Edvinsson L. Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion. Br J Pharmacol 2014;171:2726-38. [PMID: 24467585 DOI: 10.1111/bph.12606] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
48 Pelliccione F, D'Angeli A, D'Andrea S, Barbonetti A, Pezzella A, Necozione S, Falone S, Amicarelli F, Francavilla F, Francavilla S. Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with erectile dysfunction and vascular risk. Asian J Androl 2014;16:290-4. [PMID: 24407182 DOI: 10.4103/1008-682X.122347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
49 Qin Q, Chen M, Yi B, You X, Yang P, Sun J. Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells. J Mol Cell Cardiol 2014;77:20-8. [PMID: 25284689 DOI: 10.1016/j.yjmcc.2014.09.027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
50 Smith TP, Haymond T, Smith SN, Sweitzer SM. Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain. J Pain Res 2014;7:531-45. [PMID: 25210474 DOI: 10.2147/JPR.S65923] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
51 Martínez-salamanca JI, González J, Ramírez P, Angulo J. Vascular Erectile Dysfunction. PanVascular Medicine 2014. [DOI: 10.1007/978-3-642-37393-0_154-1] [Reference Citation Analysis]
52 Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013;14:5-12. [PMID: 23306778 DOI: 10.1007/s11154-012-9229-1] [Cited by in Crossref: 272] [Cited by in F6Publishing: 232] [Article Influence: 27.2] [Reference Citation Analysis]
53 Yoon MH, Reriani M, Mario G, Rihal C, Gulati R, Lennon R, Tilford JM, Lerman LO, Lerman A. Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol 2013;168:1316-21. [PMID: 23290081 DOI: 10.1016/j.ijcard.2012.12.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
54 Rocca DGD, Pepine CJ. Endothelial Dysfunction in Microvascular Angina. Chest Pain with Normal Coronary Arteries 2013. [DOI: 10.1007/978-1-4471-4838-8_8] [Reference Citation Analysis]
55 Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation 2012;126:753-67. [PMID: 22869857 DOI: 10.1161/CIRCULATIONAHA.112.093245] [Cited by in Crossref: 764] [Cited by in F6Publishing: 795] [Article Influence: 69.5] [Reference Citation Analysis]
56 Matthys KE, Bult H. Nitric oxide function in atherosclerosis. Mediators Inflamm. 1997;6:3-21. [PMID: 18472828 DOI: 10.1080/09629359791875] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
57 Porter KM, Sutliff RL. HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med 2012;53:143-59. [PMID: 22564529 DOI: 10.1016/j.freeradbiomed.2012.03.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
58 Barton M. Endothelin Receptor Antagonists in Cardiovascular Medicine: Challenges and Opportunities. Translational Vascular Medicine 2012. [DOI: 10.1007/978-0-85729-920-8_15] [Reference Citation Analysis]
59 Fogal B, Pober JS. Vascular Endothelial Cells as Immunological Targets in Atheroscleroisis. Inflammation and Atherosclerosis 2012. [DOI: 10.1007/978-3-7091-0338-8_6] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
60 Yasuno K, Bakırcıoğlu M, Low SK, Bilgüvar K, Gaál E, Ruigrok YM, Niemelä M, Hata A, Bijlenga P, Kasuya H, Jääskeläinen JE, Krex D, Auburger G, Simon M, Krischek B, Ozturk AK, Mane S, Rinkel GJ, Steinmetz H, Hernesniemi J, Schaller K, Zembutsu H, Inoue I, Palotie A, Cambien F, Nakamura Y, Lifton RP, Günel M. Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci U S A 2011;108:19707-12. [PMID: 22106312 DOI: 10.1073/pnas.1117137108] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 6.7] [Reference Citation Analysis]
61 Ribeiro AS, Fernandes VS, Orensanz LM, Martínez MP, Recio P, Martínez-Sáenz A, Climent B, Arteaga JL, García-Sacristán A, Prieto D, Hernández M. Mechanisms involved in the adenosine-induced vasorelaxation to the pig prostatic small arteries. Purinergic Signal 2011;7:413-25. [PMID: 21567127 DOI: 10.1007/s11302-011-9238-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
62 Mori M, Namba M, Muramatsu Y, Sumitomo S, Takai Y, Shikimori M. Endothelin expression in salivary gland. Oral Science International 2011;8:7-10. [DOI: 10.1016/s1348-8643(11)00005-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Sangiorgi G, Mauriello A, Trimarchi S, Bonanno E, Spagnoli LG. Atherogenesis and Inflammation. Interventional Cardiology 2011. [DOI: 10.1002/9781444319446.ch2] [Reference Citation Analysis]
64 Ergul A. Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res 2011;63:477-82. [PMID: 21292003 DOI: 10.1016/j.phrs.2011.01.012] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
65 Burg MM, Soufer A, Lampert R, Collins D, Soufer R. Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery disease. Mol Med 2011;17:495-501. [PMID: 21267513 DOI: 10.2119/molmed.2010.00083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
66 Dashwood MR, Tsui JC. Further evidence for a role of endothelin-1 (ET-1) in critical limb ischaemia. J Cell Commun Signal 2011;5:45-9. [PMID: 21484588 DOI: 10.1007/s12079-010-0109-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
67 Habib A, Al-Omari MA, Khaleghi M, Morgenthaler NG, Struck J, Bergmann A, Mosley TH, Turner ST, Kullo IJ. Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension. Am J Hypertens 2010;23:1204-8. [PMID: 20634796 DOI: 10.1038/ajh.2010.149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
68 Burg MM, Martens EJ, Collins D, Soufer R. Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosom Med 2011;73:2-6. [PMID: 20947777 DOI: 10.1097/PSY.0b013e3181fdfb25] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
69 Reriani MK, Lerman LO, Lerman A. Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med. 2010;4:351-360. [PMID: 20550469 DOI: 10.2217/bmm.10.61] [Cited by in Crossref: 74] [Cited by in F6Publishing: 84] [Article Influence: 5.7] [Reference Citation Analysis]
70 Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 2010;122:958-66. [PMID: 20733096 DOI: 10.1161/CIRCULATIONAHA.110.967406] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 8.5] [Reference Citation Analysis]
71 Fraenkl SA, Mozaffarieh M, Flammer J. Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins. EPMA J 2010;1:253-61. [PMID: 21258633 DOI: 10.1007/s13167-010-0025-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
72 de Haro Miralles J, Gónzalez AF, Varela Casariego C, García FA. Onset of peripheral arterial disease: role of endothelin in endothelial dysfunction. Interact Cardiovasc Thorac Surg 2010;10:760-5. [PMID: 20154344 DOI: 10.1510/icvts.2009.227967] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
73 Fernandez AB, Soufer R, Collins D, Soufer A, Ranjbaran H, Burg MM. Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery disease. Psychosom Med 2010;72:348-53. [PMID: 20368479 DOI: 10.1097/PSY.0b013e3181d71982] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
74 Yamashiro K, Milsom AB, Duchene J, Panayiotou C, Urabe T, Hattori N, Ahluwalia A. Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice. J Cereb Blood Flow Metab 2010;30:1494-503. [PMID: 20234380 DOI: 10.1038/jcbfm.2010.34] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
75 Nguyen A, Thorin-Trescases N, Thorin E. Working under pressure: coronary arteries and the endothelin system. Am J Physiol Regul Integr Comp Physiol 2010;298:R1188-94. [PMID: 20237301 DOI: 10.1152/ajpregu.00653.2009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
76 Thorin E, Clozel M. The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol 2010;60:1-26. [PMID: 21081213 DOI: 10.1016/B978-0-12-385061-4.00001-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
77 Thorin E, Webb DJ. Endothelium-derived endothelin-1. Pflugers Arch 2010;459:951-8. [PMID: 19967386 DOI: 10.1007/s00424-009-0763-y] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
78 Stauffer BL, Westby CM, Greiner JJ, Van Guilder GP, Desouza CA. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am J Physiol Regul Integr Comp Physiol 2010;298:R261-5. [PMID: 19939973 DOI: 10.1152/ajpregu.00626.2009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
79 Sud N, Black SM. Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression. DNA Cell Biol 2009;28:543-53. [PMID: 19754268 DOI: 10.1089/dna.2009.0865] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
80 Bernal-lópez MR, Rípodas A, Aragoncillo P, Aguado MG, Hernando FJS, Tinahones FJ, Gómez-huelgas R, Fernández-cruz A. Atheromatous plaque from human carotid artery: Potential involvement of the endothelin-1 and their receptors. Process Biochemistry 2009;44:1231-1236. [DOI: 10.1016/j.procbio.2009.06.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 de Haro Miralles J, Martínez-Aguilar E, Florez A, Varela C, Bleda S, Acin F. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs. Interact Cardiovasc Thorac Surg 2009;9:107-12. [PMID: 19376804 DOI: 10.1510/icvts.2008.196428] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
82 Groeneweg JG, Antonissen CH, Huygen FJ, Zijlstra FJ. Expression of endothelial nitric oxide synthase and endothelin-1 in skin tissue from amputated limbs of patients with complex regional pain syndrome. Mediators Inflamm 2008;2008:680981. [PMID: 18663383 DOI: 10.1155/2008/680981] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
83 Rodríguez-Pascual F, Redondo-Horcajo M, Magán-Marchal N, Lagares D, Martínez-Ruiz A, Kleinert H, Lamas S. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol Cell Biol 2008;28:7139-55. [PMID: 18809573 DOI: 10.1128/MCB.01145-08] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 6.2] [Reference Citation Analysis]
84 Torgrimson BN, Meendering JR, Miller NP, Kaplan PF, Minson CT. Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring. Fertil Steril 2009;92:441-7. [PMID: 18706555 DOI: 10.1016/j.fertnstert.2008.06.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
85 Raichlin E, Prasad A, Mathew V, Kent B, Holmes DR Jr, Pumper GM, Nelson RE, Lerman LO, Lerman A. Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis. Hypertension 2008;52:522-8. [PMID: 18695150 DOI: 10.1161/HYPERTENSIONAHA.108.113068] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
86 Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med. 2008;14:37-44. [PMID: 18068482 DOI: 10.1016/j.molmed.2007.11.004] [Cited by in Crossref: 396] [Cited by in F6Publishing: 434] [Article Influence: 26.4] [Reference Citation Analysis]
87 Bonanno E. Pathobiologic Determinants of Carotid Plaque Development. Carotid Atherosclerotic Disease 2008. [DOI: 10.3109/9780203091548-5] [Reference Citation Analysis]
88 Vanhoutte P, Boulanger C. Endothelial Function and Dysfunction. Basic Science for the Cardiologist. [DOI: 10.1007/978-0-585-38146-6_4] [Reference Citation Analysis]
89 Shah PK. Pathogenesis of Atherosclerosis. Essential Cardiology. [DOI: 10.1007/978-1-59259-918-9_22] [Reference Citation Analysis]
90 Denton C, Black C. Blocage de l'endothéline dans la sclérodermie systémique : rationnel et bénéfice clinique. La Revue de Médecine Interne 2007;28:S214-S220. [DOI: 10.1016/s0248-8663(07)80019-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Peppiatt-Wildman CM, Albert AP, Saleh SN, Large WA. Endothelin-1 activates a Ca2+-permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes. J Physiol 2007;580:755-64. [PMID: 17303636 DOI: 10.1113/jphysiol.2006.126656] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
92 Obineche E, Abdulle AM, Bokhari AM, Yasin JY, Gillett MP. Circulating levels of endothelin-1 in a homogenous Gulf Arab population with untreated essential hypertension. Ann Saudi Med 2006;26:364-9. [PMID: 17019099 DOI: 10.5144/0256-4947.2006.364] [Reference Citation Analysis]
93 Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol 2006;:295-329. [PMID: 16999223 DOI: 10.1007/3-540-32967-6_9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 4.9] [Reference Citation Analysis]
94 Singh G, Maguire JJ, Kuc RE, Skepper JN, Fidock M, Davenport AP. Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation. Br J Pharmacol. 2006;149:838-844. [PMID: 17043672 DOI: 10.1038/sj.bjp.0706924] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
95 Verdecchia P, Angeli F, Sardone M, Gattobigio R. Serial Changes in Left Ventricular Mass in Hypertension: Prognostic Impact. Emerging Pathologies in Cardiology. [DOI: 10.1007/88-470-0341-5_9] [Reference Citation Analysis]
96 Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 2005;568:357-69. [PMID: 16051630 DOI: 10.1113/jphysiol.2005.089755] [Cited by in Crossref: 415] [Cited by in F6Publishing: 429] [Article Influence: 23.1] [Reference Citation Analysis]
97 Frantz RP, Olson LJ, Grill D, Moualla SK, Nelson SM, Nobrega TP, Hanna RD, Backes RJ, Mookadam F, Heublein D, Bailey KR, Burnett JC. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure. Am Heart J 2005;149:541-7. [PMID: 15864245 DOI: 10.1016/j.ahj.2004.07.036] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
98 Pharmakakis NM, Andrikopoulos GK, Nanos PD, Papadopoulos GE, Xenopoulos SP, Theodorou GL, Petropoulos IK, Karakantza MD. Plasma and Aqueous Humor Endothelin-1 Levels in Patients With Noninsulin-Dependent Diabetes Mellitus With and Without Retinopathy. The Endocrinologist 2005;15:82-86. [DOI: 10.1097/01.ten.0000157892.21640.a4] [Reference Citation Analysis]
99 Schirger JA, Boerrigter G, Burnett JC. Endothelin in Hypertension. Hypertension 2005. [DOI: 10.1016/b978-0-7216-0258-5.50107-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Stokes KY, Granger DN. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? J Physiol. 2005;562:647-653. [PMID: 15611017 DOI: 10.1113/jphysiol.2004.079640] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 3.5] [Reference Citation Analysis]
101 Wiley KE, Davenport AP. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol 2004;143:508-14. [PMID: 15381637 DOI: 10.1038/sj.bjp.0705985] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 3.8] [Reference Citation Analysis]
102 Mickey I, Kilford L, Kingsbury A, Loesch A. Endothelin in the middle cerebral artery: a case of multiple system atrophy. Histochem J 2002;34:469-77. [PMID: 12945729 DOI: 10.1023/a:1024758504647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
103 Eskurza I, Monahan KD, Robinson JA, Seals DR. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004;556:315-24. [PMID: 14754992 DOI: 10.1113/jphysiol.2003.057042] [Cited by in Crossref: 243] [Cited by in F6Publishing: 256] [Article Influence: 12.8] [Reference Citation Analysis]
104 Verdecchia P, Angeli F. Reversal of left ventricular hypertrophy: what have recent trials taught us? Am J Cardiovasc Drugs 2004;4:369-78. [PMID: 15554722 DOI: 10.2165/00129784-200404060-00005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
105 Leclerc J. Antiplatelet therapy in acute brain ischemia. Acute Stroke Treatment 2003. [DOI: 10.1201/b14341-12] [Reference Citation Analysis]
106 Murphy TP. Renal Ischemia as a Predictor of Cardiovascular Morbidity. Journal of Vascular and Interventional Radiology 2003;14:P159-P164. [DOI: 10.1016/s1051-0443(03)70144-4] [Reference Citation Analysis]
107 Kumazaki T. Aging of Endothelial Cells. Aging of Cells in and Outside the Body 2003. [DOI: 10.1007/978-94-017-0669-8_4] [Reference Citation Analysis]
108 Cachofeiro Ramos V, Vázquez-pérez S, de las Heras Jiménez N, Cediel Gil E, Sanz-rosa D, Olivares E, Lahera Juliá V. Hipercolesterolemia y disfunción endotelial: mecanismos implicados. Hipertensión y Riesgo Vascular 2003;20:116-126. [DOI: 10.1016/s1889-1837(03)71363-4] [Reference Citation Analysis]
109 Orzechowski H. Endothelin-dependent modulation of vasoconstrictor action in the coronary circulation in early salt-induced experimental hypertension. Journal of Hypertension 2003;21:27-29. [DOI: 10.1097/00004872-200301000-00007] [Reference Citation Analysis]
110 Fernandez-Patron C, Zouki C, Whittal RM, Chan JS, Davidge ST, Filep J Já. Methods for Analysis of Matrix Metalloproteinase Regulation of Neutrophil-Endothelial Cell Adhesion. Biol Proced Online 2002;4:38-48. [PMID: 12734570 DOI: 10.1251/bpo32] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
111 Wenzel RR, Czyborra P, Lüscher T, Philipp T. Endothelin in cardiovascular control: the role of endothelin antagonists. Curr Hypertens Rep 1999;1:79-87. [PMID: 10981046 DOI: 10.1007/s11906-999-0077-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
112 Schächinger V, Zeiher AM. Coronary Artery Disease and Endothelial Function. Pan Vascular Medicine 2002. [DOI: 10.1007/978-3-642-56225-9_55] [Reference Citation Analysis]
113 Harvey SA, Gandhi CR, Behal RH, Olson MS. Down-regulation and recovery of endothelin-1 binding and signaling in rat cardiomyocytes. Biochem Biophys Res Commun 2001;288:558-63. [PMID: 11676479 DOI: 10.1006/bbrc.2001.5812] [Reference Citation Analysis]
114 Moreau R, Zhang W, Hagen T. Cellular Effects of Lipoic Acid and Its Role in Aging. Handbook of Antioxidants 2001. [DOI: 10.1201/9780203904046.ch24] [Reference Citation Analysis]
115 Kiowski W, Sütsch G, Oechslin E, Bertel O. Hemodynamic effects of bosentan in patients with chronic heart failure. Heart Fail Rev 2001;6:325-34. [PMID: 11447307 DOI: 10.1023/a:1011460426786] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
116 Spieker LE, Noll G, Ruschitzka FT, Lüscher TF. Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched? Heart Fail Rev 2001;6:301-15. [PMID: 11447305 DOI: 10.1023/a:1011456309039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
117 Wiley KE, Davenport AP. Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol 2001;133:568-74. [PMID: 11399674 DOI: 10.1038/sj.bjp.0704119] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
118 Favarato D, de Padua Mansur A. Effect of Controlling Hypercholesterolemia on Myocardial Ischemia. Preventive Cardiology 2001;4:126-131. [DOI: 10.1111/j.1520-037x.2001.00536.x] [Reference Citation Analysis]
119 Ellahham SH, Charlon V, Abassi Z, Calis KA, Choucair WK. Bosentan and the endothelin system in congestive heart failure. Clin Cardiol 2000;23:803-7. [PMID: 11097125 DOI: 10.1002/clc.4960231128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
120 Burnett JC Jr. Coronary endothelial function in health and disease. Drugs 1997;53 Suppl 1:20-9. [PMID: 9034752 DOI: 10.2165/00003495-199700531-00005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
121 Spieker LE, Noll G, Lüscher TF. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders. Am J Cardiovasc Drugs 2001;1:293-303. [PMID: 14728028 DOI: 10.2165/00129784-200101040-00007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
122 Simonson MS. Cell Signaling by Endothelin Peptides. Endothelin and Its Inhibitors 2001. [DOI: 10.1007/978-3-642-56899-2_5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
123 Kousta E, Franks S. Long-term health consequences of polycystic ovary syndrome. Polycystic Ovary Syndrome 2001. [DOI: 10.1017/cbo9780511545191.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
124 Wachi H, Sugitani H, Tajima S, Seyama Y. Endothelin-1 Down-Regulates Expression of Tropoelastin and Lysyl Oxidase mRNA in Cultured Chick Aortic Smooth Muscle Cells. JOURNAL OF HEALTH SCIENCE 2001;47:525-532. [DOI: 10.1248/jhs.47.525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
125 Barton M. Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics. Curr Hypertens Rep 2000;2:84-91. [PMID: 10981133 DOI: 10.1007/s11906-000-0064-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
126 Morawietz H, Talanow R, Szibor M, Rueckschloss U, Schubert A, Bartling B, Darmer D, Holtz J. Regulation of the endothelin system by shear stress in human endothelial cells. J Physiol 2000;525 Pt 3:761-70. [PMID: 10856127 DOI: 10.1111/j.1469-7793.2000.00761.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 5.0] [Reference Citation Analysis]
127 Tanner FC, Lüscher TF. Pathophysiology of Intimal Hyperplasia. Radiology of Peripheral Vascular Diseases 2000. [DOI: 10.1007/978-3-642-56956-2_4] [Reference Citation Analysis]
128 Van de Voorde J, Vanheel B. Endothelial Modulation of Vascular Tone. Textbook of Angiology 2000. [DOI: 10.1007/978-1-4612-1190-7_2] [Reference Citation Analysis]
129 Zouki C, Baron C, Fournier A, Filep JG. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol. 1999;127:969-979. [PMID: 10433505 DOI: 10.1038/sj.bjp.0702593] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 3.5] [Reference Citation Analysis]
130 Thorin É, Parent R, Ming Z, Lavallée M. Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans. American Journal of Physiology-Heart and Circulatory Physiology 1999;277:H524-H532. [DOI: 10.1152/ajpheart.1999.277.2.h524] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
131 Kamath PS, Tyce GM, Miller VM, Edwards BS, Rorie DK. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology 1999;30:401-7. [PMID: 10421647 DOI: 10.1002/hep.510300235] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
132 Maguire JJ, Davenport AP. Endothelin receptor expression and pharmacology in human saphenous vein graft. Br J Pharmacol 1999;126:443-50. [PMID: 10077237 DOI: 10.1038/sj.bjp.0702326] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
133 Galatius S, Wroblewski H, Sørensen VB, Bie P, Parving H, Kastrup J. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: Different stimuli for release before and after heart transplantation? American Heart Journal 1999;137:549-54. [DOI: 10.1016/s0002-8703(99)70505-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
134 Brooks DP, Ohlstein EH. Endothelin and the Heart. Hormones and the Heart in Health and Disease 1999. [DOI: 10.1007/978-1-59259-708-6_10] [Reference Citation Analysis]
135 Moulton AW. Cardiovascular Changes in Menopause. Menopause 1999. [DOI: 10.1007/978-1-59259-246-3_3] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
136 Barton M, Haudenschild CC, d’Uscio LV, Shaw S, Münter K, Lüscher TF. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 1998;95:14367-14372. [PMID: 9826706 DOI: 10.1073/pnas.95.24.14367] [Cited by in Crossref: 268] [Cited by in F6Publishing: 273] [Article Influence: 10.7] [Reference Citation Analysis]
137 Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR. Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol 1998;82:498-503. [PMID: 9713055 DOI: 10.1136/bjo.82.5.498] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
138 Voets AJ, Van Zwienen J, Van Der Starre P. Endothelin and acute renal dysfunction after coronary artery bypass grafting. Clinical Intensive Care 1998;9:153-160. [DOI: 10.3109/tcic.9.4.153.160] [Reference Citation Analysis]
139 Shi D, Chen K, Zhang Q, Zhong P, Zhu Y, Fu X. Effect of purified Xuefu Capsule on endothelin, nitric oxide synthetase gene expression of vascular wall in atherosclerotic rabbits. CJIM 1998;4:123-5. [DOI: 10.1007/bf02934158] [Reference Citation Analysis]
140 Berkenboom G, Crasset V, Giot C, Unger P, Vachiery JL, LeClerc JL. Endothelial function of internal mammary artery in patients with coronary artery disease and in cardiac transplant recipients. Am Heart J 1998;135:488-94. [PMID: 9506335 DOI: 10.1016/s0002-8703(98)70326-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
141 Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C, Housset C. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998;27:472-80. [PMID: 9462646 DOI: 10.1002/hep.510270222] [Cited by in Crossref: 167] [Cited by in F6Publishing: 173] [Article Influence: 6.7] [Reference Citation Analysis]
142 Goligorsky MS, Winaver JM. Functional Coordination and Cooperation Between Endothelin and Nitric Oxide Systems in Vascular Regulation. Endothelin Receptors and Signaling Mechanisms 1998. [DOI: 10.1007/978-3-662-11672-2_5] [Reference Citation Analysis]
143 Simonson MS. Endothelin Signaling to the Nucleus: Regulation of Gene Expression and Phenotype. Endothelin Receptors and Signaling Mechanisms 1998. [DOI: 10.1007/978-3-662-11672-2_12] [Reference Citation Analysis]
144 Stula M, Schott E, Paul M. Bedeutung peptiderger Systeme bei der Genese kardiovaskulärer Erkrankungen. Herz-Kreislauf-Erkrankungen 1998. [DOI: 10.1007/978-3-642-80360-4_11] [Reference Citation Analysis]
145 Wenzel RR, Noll G, Lüscher TF. Das koronare Gefäßendothel. Herzerkrankungen und Interventions-möglichkeiten 1998. [DOI: 10.1007/978-3-642-80404-5_7] [Reference Citation Analysis]
146 Frishman WH, Tamirisa P, Kumar A. Endothelins and their role in hypertension. Baillière's Clinical Anaesthesiology 1997;11:561-580. [DOI: 10.1016/s0950-3501(97)80042-6] [Reference Citation Analysis]
147 Zhang W, Bammer T, Binder B, Wojta J. Effect of endothelin on the regulation of the fibrinolytic system of cultured human vascular smooth muscle cells. Fibrinolysis and Proteolysis 1997;11:245-250. [DOI: 10.1016/s0268-9499(97)80108-7] [Reference Citation Analysis]
148 Buckley CH, Hadoke PW, O'Brien CJ. Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma. Br J Ophthalmol 1997;81:599-607. [PMID: 9290378 DOI: 10.1136/bjo.81.7.599] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
149 Douglas S, Feuerstein G. Pharmacological treatments for restenosis. Emerging Drugs 1997;2:29-72. [DOI: 10.1517/14728214.2.1.29] [Reference Citation Analysis]
150 Lüscher TF, Noll G, Boulanger CM. Endothelial Dysfunction after Angioplasty: A Pathway for Remodelling? Arterial Remodeling: A Critical Factor in Restenosis 1997. [DOI: 10.1007/978-1-4615-6079-1_12] [Reference Citation Analysis]
151 Ros J, Leivas A, Jiménez W, Morales M, Bosch-Marcé M, Arroyo V, Rivera F, Rodés J. Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells. J Hepatol 1997;26:81-7. [PMID: 9148027 DOI: 10.1016/s0168-8278(97)80013-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
152 Haynes WG, Webb DJ. The Endothelins. Molecular and Cellular Endocrinology 1997. [DOI: 10.1016/s1569-2582(97)80171-7] [Reference Citation Analysis]
153 Webb DJ, Gray GA. Vascular Biology of the Endothelin System. Endothelial Function in Hypertension 1997. [DOI: 10.1007/978-3-642-60811-7_6] [Reference Citation Analysis]
154 Borgeson DD, Mckinley LJ, Burnett JC. Endothelin in Congestive Heart Failure: Pathophysiology and Therapeutic Implications. Endothelial Function in Hypertension 1997. [DOI: 10.1007/978-3-642-60811-7_9] [Reference Citation Analysis]
155 Webb DJ. Endothelin in Human Cardiovascular Physiology and Pathophysiology. Endothelial Function in Hypertension 1997. [DOI: 10.1007/978-3-642-60811-7_10] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
156 REVIEW. Clinical Chemistry and Laboratory Medicine 1997;35. [DOI: 10.1515/cclm.1997.35.3.175] [Reference Citation Analysis]
157 Niranjan V, Télémaque S, deWit D, Gerard RD, Yanagisawa M. Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats. J Clin Invest 1996;98:2364-72. [PMID: 8941655 DOI: 10.1172/JCI119049] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
158 Walter M, Reinecke H, Gerdes U, Nofer JR, Höbbel G, Seedorf U, Assmann G. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J Clin Invest 1996;98:2315-23. [PMID: 8941649 DOI: 10.1172/JCI119043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
159 Wang Y, Simonson MS. Voltage-insensitive Ca2+ channels and Ca2+/calmodulin-dependent protein kinases propagate signals from endothelin-1 receptors to the c-fos promoter. Mol Cell Biol 1996;16:5915-23. [PMID: 8816505 DOI: 10.1128/MCB.16.10.5915] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 1.8] [Reference Citation Analysis]
160 Weitzberg E, Hemsén A, Rudehill A, Modin A, Wanecek M, Lundberg JM. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock. Br J Pharmacol 1996;118:617-26. [PMID: 8762086 DOI: 10.1111/j.1476-5381.1996.tb15446.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 1.9] [Reference Citation Analysis]
161 Clavell AL, Mattingly MT, Stevens TL, Nir A, Wright S, Aarhus LL, Heublein DM, Burnett JC Jr. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. J Clin Invest 1996;97:1286-92. [PMID: 8636441 DOI: 10.1172/JCI118544] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 2.0] [Reference Citation Analysis]
162 Bacon CR, Davenport AP. Endothelin receptors in human coronary artery and aorta. Br J Pharmacol 1996;117:986-92. [PMID: 8851522 DOI: 10.1111/j.1476-5381.1996.tb15292.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
163 Levin ER. The Endothelin Peptides. Endocrinology of the Vasculature 1996. [DOI: 10.1007/978-1-4612-0231-8_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
164 Noll G, Wenzel RR, Lüscher TF. Endothelin and endothelin antagonists: Potential role in cardiovascular and renal disease. Biochemistry of Signal Transduction in Myocardium 1996. [DOI: 10.1007/978-1-4613-1275-8_34] [Reference Citation Analysis]
165 Kaski JC. The role of vascular endothelium in the modulation of coronary vasomotor tone. Developments in Cardiovascular Medicine 1996. [DOI: 10.1007/978-94-011-5406-2_5] [Reference Citation Analysis]
166 Wickham NWR, Bradshaw A, Evans J, Bevan DH, Mansi J. Endothelial Function and Malignant Coagulopathy. Vascular Endothelium 1996. [DOI: 10.1007/978-1-4613-0355-8_83] [Reference Citation Analysis]
167 Lüscher TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors. Molecular Reviews in Cardiovascular Medicine 1996. [DOI: 10.1007/978-94-009-0083-7_12] [Reference Citation Analysis]
168 POSTER COMMUNICATIONS. British Journal of Pharmacology 1995;116:342P-458P. [DOI: 10.1111/j.1476-5381.1995.tb16907.x] [Reference Citation Analysis]
169 Kaski JC, Elliott PM, Salomone O, Dickinson K, Gordon D, Hann C, Holt DW. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995;74:620-4. [PMID: 8541166 DOI: 10.1136/hrt.74.6.620] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 3.1] [Reference Citation Analysis]
170 Perfetto F, Tarquini R, de Leonardis V, Piluso A, Lombardi V, Tarquini B. Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients. Acta Diabetol 1995;32:263-7. [PMID: 8750766 DOI: 10.1007/BF00576260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
171 Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995;92:11190-4. [PMID: 7479963 DOI: 10.1073/pnas.92.24.11190] [Cited by in Crossref: 460] [Cited by in F6Publishing: 482] [Article Influence: 16.4] [Reference Citation Analysis]
172 Tamirisa P, Frishman WH, Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J 1995;130:601-10. [PMID: 7661079 DOI: 10.1016/0002-8703(95)90370-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.4] [Reference Citation Analysis]
173 Kaiser HJ, Flammer J, Wenk M, Lüscher T. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol 1995;233:484-8. [PMID: 8537023 DOI: 10.1007/BF00183429] [Cited by in Crossref: 107] [Cited by in F6Publishing: 122] [Article Influence: 3.8] [Reference Citation Analysis]
174 Sabry S, Mondon F, Levy M, Ferré F, Dinh-Xuan AT. Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteries. Br J Pharmacol 1995;115:1038-42. [PMID: 7582500 DOI: 10.1111/j.1476-5381.1995.tb15915.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
175 Breu V, Hashido K, Broger C, Miyamoto C, Furuichi Y, Hayes A, Kalina B, Loffler B, Ramuz H, Clozel M. Separable Binding Sites for the Natural Agonist Endothelin-1 and the Non-Peptide Antagonist Bosentan on Human Endothelin-A Receptors. Eur J Biochem 1995;231:266-270. [DOI: 10.1111/j.1432-1033.1995.0266f.x] [Reference Citation Analysis]
176 Fujitani Y, Ninomiya H, Okada T, Urade Y, Masaki T. Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta. J Clin Invest 1995;95:2474-82. [PMID: 7769093 DOI: 10.1172/JCI117948] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
177 Münzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A 1995;92:5244-8. [PMID: 7539147 DOI: 10.1073/pnas.92.11.5244] [Cited by in Crossref: 145] [Cited by in F6Publishing: 148] [Article Influence: 5.2] [Reference Citation Analysis]
178 Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol 1995;114:925-30. [PMID: 7780646 DOI: 10.1111/j.1476-5381.1995.tb13292.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 2.9] [Reference Citation Analysis]
179 Yu JC, Davenport AP. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol 1995;114:551-7. [PMID: 7881755 DOI: 10.1111/j.1476-5381.1995.tb13262.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 2.1] [Reference Citation Analysis]
180 Fernandez-cruz A, Patiño R, Ibarra J, Fernandez L, Roldan M, Moya J, Fernandez-durango R. Endothelin in Hypertension and Diabetes Mellitus. The Endothelium in Cardiovascular Disease 1995. [DOI: 10.1007/978-3-642-79803-0_13] [Reference Citation Analysis]
181 Predel HG, Knigge H, Prinz U, Stalleicken D, Kramer HJ, Rost RE. The exercise-induced increase in plasma levels of endothelin-1 is enhanced in patients with atherosclerotic coronary artery disease. Modulation by pentaerithrityltetranitrat (PETN). Agents Actions Suppl 1995;45:219-25. [PMID: 7717184 DOI: 10.1007/978-3-0348-7346-8_32] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
182 Berliner JA, Watson AD. The Role of Oxidized Lipids in Cardiovascular Disease. Active Oxygen in Biochemistry 1995. [DOI: 10.1007/978-94-011-0609-2_10] [Reference Citation Analysis]
183 Predel H, Knigge H, Rohden C, Prinz U, Stalleicken D, Kramer HJ, Rost R. Pentaerithrityltetranitrat (PETN) inhibiert den belastungsinduzierten Anstieg der Endothelin- (ET) 1 Plasmaspiegel bei Patienten mit koronarer Herzkrankheit (KHK). Pentaerithrityltetranitrat 1995. [DOI: 10.1007/978-3-642-72525-8_7] [Reference Citation Analysis]
184 Matheis G, Beyersdorf F. Increased preoperative endothelin release in patients with vascular disease. J Vasc Surg 1994;20:1006. [PMID: 7990176 DOI: 10.1016/0741-5214(94)90241-0] [Reference Citation Analysis]
185 Wieczorek I, Haynes WG, Webb DJ, Ludlam CA, Fox KA. Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 1994;72:436-41. [PMID: 7818960 DOI: 10.1136/hrt.72.5.436] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 1.9] [Reference Citation Analysis]
186 Velasco CE, Turner M, Inagami T, Atkinson JB, Virmani R, Jackson EK, Murray JJ, Forman MB. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J 1994;128:441-51. [PMID: 8074003 DOI: 10.1016/0002-8703(94)90615-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
187 Ohwaki T, Sakai H, Hirata Y. Partial characterization of endothelin-converting enzyme activity in human serum lipoproteins. Atherosclerosis 1994;108:175-81. [PMID: 7980717 DOI: 10.1016/0021-9150(94)90112-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
188 Dashwood MR, Allen SP, Luu TN, Muddle JR. The effect of the ETA receptor antagonist, FR 139317, on [125I]-ET-1 binding to the atherosclerotic human coronary artery. Br J Pharmacol 1994;112:386-9. [PMID: 7521255 DOI: 10.1111/j.1476-5381.1994.tb13083.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
189 Stehouwer CDA. Von Willebrand Factor and the Development of Renal and Vascular Complications in Diabetes. The Kidney and Hypertension in Diabetes Mellitus 1994. [DOI: 10.1007/978-1-4757-6746-9_12] [Reference Citation Analysis]
190 Prat L, Torres G, Carrió I, Roca M, Riambau V, Berná L, Estorch M, Ferrer I, García C. Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury. Eur J Nucl Med 1993;20:1141-5. [PMID: 8299648 DOI: 10.1007/BF00171011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
191 Dietz U, Erbel R, Rupprecht HJ, Weidmann S, Meyer J. High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions. Br Heart J 1993;70:327-36. [PMID: 8217440 DOI: 10.1136/hrt.70.4.327] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
192 Gulbins E, Hoffend J, Zou AP, Dietrich MS, Schlottmann K, Cavarape A, Steinhausen M. Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys. J Physiol 1993;469:571-82. [PMID: 8271216 DOI: 10.1113/jphysiol.1993.sp019830] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.7] [Reference Citation Analysis]
193 Zimmerman RS. A potential role for endothelin in congestive heart failure. Mayo Clin Proc 1992;67:801-3. [PMID: 1434921 DOI: 10.1016/s0025-6196(12)60807-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
194 Leithner C. Das Versagen des Organs im Rahmen des Multiorganversagens: Welche Fragen sind offen? Niere. Multiorganversagen 1992. [DOI: 10.1007/978-3-7091-9201-6_10] [Reference Citation Analysis]